Dimethyl fumarate reduces the frequency and function of inflammatory immune cells in relapsing-remitting multiple sclerosis patients

被引：0
|
作者：
Diaz, G. Montes [1 ,2 ,3 ]
Fraussen, J. [1 ,2 ,3 ]
Van Wijmeersch, B. [1 ,2 ,3 ,4 ]
Hupperts, R. [5 ,6 ]
Somers, V. [1 ,2 ,3 ]
机构：
[1] Univ Limburg, Biomed Res Inst, Maastricht, Netherlands
[2] Univ Limburg, Transnat, Maastricht, Netherlands
[3] Hasselt Univ, Sch Life Sci, Diepenbeek, Belgium
[4] Rehabil & MS Ctr, Overpelt, Belgium
[5] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Neurosci, Maastricht, Netherlands
[6] Zuyderland Med Ctr, Acad MS Ctr Limburg, Sittard, Netherlands
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1169
引用
收藏
页码：616 / 617
页数：2
相关论文
共 50 条
  • [21] Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives
    Ozel, Osman
    Vaughn, Caila B.
    Eckert, Svetlana P.
    Jakimovski, Dejan
    Lizarraga, Alexis A.
    Weinstock-Guttman, Bianca
    PATIENT-RELATED OUTCOME MEASURES, 2019, 10 : 373 - 384
  • [22] Early versus delayed initiation of fingolimod or dimethyl fumarate in relapsing-remitting multiple sclerosis
    Lorscheider, J.
    Schadelin, S.
    Benkert, P.
    Lienert, C.
    Hanni, P.
    Derfuss, T.
    Decard, B.
    Kuhle, J.
    Kappos, L.
    Yaldizli, O.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 257 - 258
  • [23] A case of Legionnaires' disease in a patient on dimethyl fumarate therapy for relapsing-remitting multiple sclerosis
    Brandstadter, R.
    Sand, I. Katz
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 871 - 872
  • [24] Natalizumab reduces apathy in relapsing-remitting multiple sclerosis patients
    Berkovich, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S154 - S155
  • [25] Acute pancreatitis: possible association of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis
    Hongxiu Luo
    Harsh Bhatt
    Shaza Mohamad
    Eric Uhrik
    Shuvendu Sen
    Teena Mathew
    Abdalla Yousif
    Journal of Neurology, 2015, 262 : 779 - 780
  • [26] Dimethyl Fumarate-Induced Takotsubo Cardiomyopathy in a Patient With Relapsing-Remitting Multiple Sclerosis
    Srichawla, Bahadar S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [27] Differential effects of dimethyl fumarate on peripheral blood mononuclear cells of relapsing-remitting multiple sclerosis patients and prognostic implications
    Sanchez Sanz, A.
    Moreno Torres, I.
    Garcia Grande, A.
    Rodriguez Esparragoza, L.
    Elvira, V.
    Marconi, M.
    Sabin Munoz, J.
    Garcia Hernandez, R.
    Rodriguez de la Fuente, O.
    Campos Ruiz, L.
    Garcia Merino, A.
    Sanchez Lopez, A. J.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 891 - 891
  • [28] Diroximel fumarate and dimethyl fumarate demonstrate early clinical and radiological efficacy in relapsing-remitting multiple sclerosis
    Singer, Barry A.
    Shafer, S. James
    Arnold, Douglas L.
    Bowen, James D.
    LaGanke, Christopher
    Chen, Hailu
    Hanna, Jerome
    Miller, Catherine
    Leigh-Pemberton, Richard
    Naismith, Robert T.
    NEUROLOGY, 2020, 94 (15)
  • [29] Prospective Observational Study in a Cohort of Patients Affected by Relapsing-Remitting Multiple Sclerosis Treated with Dimethyl Fumarate
    Di Cristinzi, Maria
    Moiola, Lucia
    Pisa, Marco
    Sangalli, Francesca
    Dalla Costa, Gloria
    Radaelli, Marta
    Preziosa, Paolo
    Romeo, Marzia
    Boneschi, Filippo Martinelli
    Colombo, Bruno
    Esposito, Federica
    Martinelli, Vittorio
    Comi, Giancarlo
    NEUROLOGY, 2018, 90
  • [30] Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis
    Alroughani, Raed
    Huppke, Peter
    Mazurkiewicz-Beldzinska, Maria
    Blaschek, Astrid
    Valis, Martin
    Aaen, Gregory
    Pultz, Joe
    Peng, Xiaomei
    Beynon, Vanessa
    FRONTIERS IN NEUROLOGY, 2021, 11
12345